tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jupiter Life Line Hospitals Publishes Q3 and Nine-Month FY2025 Unaudited Results

Story Highlights
  • Jupiter Life Line Hospitals reported higher revenue and steady profits for Q3 and nine months FY2025.
  • The unaudited financial results were approved by the board and disclosed via newspapers and the company website in line with SEBI norms.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jupiter Life Line Hospitals Publishes Q3 and Nine-Month FY2025 Unaudited Results

Claim 50% Off TipRanks Premium

The latest announcement is out from Jupiter Life Line Hospitals Ltd. ( (IN:JLHL) ).

Jupiter Life Line Hospitals Ltd. has published its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, following approval by its board on January 30, 2026. The company reported growth in operational income, with consolidated revenue from operations reaching ₹3,744.96 million for the quarter and ₹11,451.68 million for the nine-month period, alongside steady profitability reflected in net profit and earnings per share metrics. The results were released via newspaper advertisements in Financial Express and the Marathi daily Pudhari and are also available on the company’s website, underscoring its compliance with SEBI’s disclosure norms and providing investors and other stakeholders with updated visibility into its financial performance for the current fiscal year.

More about Jupiter Life Line Hospitals Ltd.

Jupiter Life Line Hospitals Ltd. is a multi-specialty healthcare provider operating hospitals in Maharashtra, including facilities in Thane, Pune and Mumbai. The company focuses on tertiary and quaternary care services and caters to a broad patient base through its network of hospitals and related clinical offerings.

Average Trading Volume: 756

Technical Sentiment Signal: Strong Sell

Current Market Cap: 88.23B INR

See more data about JLHL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1